Thrombosis and Haemostasis
Overview
Thrombosis and Haemostasis is a peer-reviewed medical journal that focuses on the study of blood clotting disorders and their prevention, diagnosis, and treatment. It publishes original research articles, reviews, and case reports, providing valuable insights into the mechanisms, risk factors, and therapeutic interventions for thrombosis and haemostatic disorders. The journal serves as a vital resource for clinicians, researchers, and healthcare professionals in the field of vascular biology and coagulation.
Details
Details
Abbr.
Thromb Haemost
Publisher
Thieme
Start
1976
End
Continuing
Frequency
Monthly
p-ISSN
0340-6245
e-ISSN
2567-689X
Country
Germany
Language
English
Specialties
Hematology
Cardiology & Vascular Diseases
Cardiology & Vascular Diseases
Metrics
Metrics
h-index / Ranks: 659
206
SJR / Ranks: 2663
1248
CiteScore / Ranks: 1286
10.50
JIF / Ranks: 910
6.7
Recent Articles
1.
Kamikubo Y, Nagaya S, Inoue R, Yamaguchi K, Morimoto-Kamata R, Morishita E, et al.
Thromb Haemost
. 2025 Mar;
PMID: 40049601
Background And Objectives: Initial thrombin (FIIa) generated via the tissue factor (TF) pathway plays a crucial role in amplifying coagulation. There is growing evidence that the TF pathway might contribute...
2.
3.
Yu X, Jia X, Wang T, Zhang Y, Song H, Li K, et al.
Thromb Haemost
. 2025 Mar;
PMID: 40049586
Patients with coronavirus disease 2019 (COVID-19) are at high risk of developing a hypercoagulable state and thrombosis. The von Willebrand factor (vWF) produced by endothelial cells (ECs) is a critical...
4.
Gregorio T, Creeper K, Pagliani L, Providencia R, Buzea A, Wallenhorst C, et al.
Thromb Haemost
. 2025 Mar;
PMID: 40043741
The duration of anticoagulation treatment for venous thromboembolism (VTE) depends on whether the event was provoked or unprovoked. Major surgery or trauma are well-established major provoking factors associated with a...
5.
Nagao A, Goto S, Goto S
Thromb Haemost
. 2025 Feb;
PMID: 40020742
As the life expectancy of individuals with hemophilia continues to increase, the complexity of balancing bleeding risks and thrombotic management has become increasingly critical in people with hemophilia with or...
6.
Kaisaier W, Chen Y, Lip G, Liu C, Zhu W
Thromb Haemost
. 2025 Feb;
PMID: 39993439
Background: Atrial fibrillation (AF) is prevalent in dialysis-dependent patients, who face higher risks of thromboembolism and bleeding. Although vitamin K antagonists (VKAs) are commonly used for anticoagulation, the benefits of...
7.
Janata K, Lipa A, Merrelaar A, Merrelaar M, Azizi-Semrad U, Herkner H, et al.
Thromb Haemost
. 2025 Feb;
PMID: 39993438
Background: Pulmonary embolism (PE) requires accurate risk assessment. We investigated the prognostic performance of the National Early Warning Score (NEWS) in emergency department patients with PE. Methods: We included patients...
8.
9.
Lee K, Cha M, Kwon I, Kim S, Song J, Kim Y, et al.
Thromb Haemost
. 2025 Feb;
PMID: 39961346
Background: Inflammatory cells may play a role in thrombus formation. However, the impact of monocytes in thrombosis and clinical characteristics of patients with monocyte-rich thrombus are less well understood. Methods: ...
10.
Ataullakhanov F, Dashkevich N, Ovsepyan R, Vuimo T, Balandina A, Kuprash A, et al.
Thromb Haemost
. 2025 Feb;
PMID: 39961345
Background: Various reactions are involved in the phases of activation and further propagation of coagulation in space. The effects of different anticoagulants on these phases are unknown. Our aim was...